Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies. Founded by Wes Kaupinen in 2015, Palvella Therapeutics is backed by investors that include Adams Street Partners, Ligand Pharmaceuticals, Samsara BioCapital, BioAdvance, and Agent Capital and is headquartered in Wayne.
FOUNDED:
2015
INDUSTRY:
Biotechnology, Health Care, Life Science, Therapeutics
FOUNDERS:
Wes Kaupinen
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
